Christa Maes

Dr. Christa Maes


Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2010 in Developmental Cell
Verified
Journal Article
Closed access
CMChrista Maes
Christa Maes
TKTatsuya Kobayashi
Tatsuya Kobayashi
MSMartin K. Selig
Martin K. Selig
STSophie Torrekens
Sophie Torrekens
SRSanford I. Roth
Sanford I. Roth
HKHenry M. Kronenberg
Henry M. Kronenberg

1 February 2002 in Mechanisms of Development
Verified
Journal Article
Closed access
CMChrista Maes
Christa Maes
PCPeter Carmeliet
Peter Carmeliet
KMKaren Moermans
Karen Moermans
ISIngrid Stockmans
Ingrid Stockmans
NSNico Smets
Nico Smets
GCGeert Carmeliet
Geert Carmeliet

1 August 2009 in Journal of Bone and Mineral Research
Verified
Journal Article
Open access
PDF file
ESErnestina Schipani
Ernestina Schipani
CMChrista Maes
Christa Maes
GCGeert Carmeliet
Geert Carmeliet
GSGregg L Semenza
Gregg L Semenza
Bone is a highly vascularized tissue, but the function of angiogenesis in bone modeling and remodeling is still poorly defined, and the molecular mechanisms that regulate angiogenesis in bone are only partially elucidated. Genetic manipulations in mice have recently highlighted the critical role of the hypoxia-inducible-factor/vascular endothelial growth factor pathway in coupling angiogenesis and osteogenesis. In this brief perspective, we review the current understanding of the mechanisms responsible for this coupling. Elucidation of such mechanisms will expand our knowledge of bone development and homeostasis, and it may aid in the design of new therapies for accelerating bone regeneration and repair.

1 December 2006 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
RMRitsuko Masuyama
Ritsuko Masuyama
ISIngrid Stockmans
Ingrid Stockmans
STSophie Torrekens
Sophie Torrekens
RLRiet Van Looveren
Riet Van Looveren
CMChrista Maes
Christa Maes
GCGeert Carmeliet
Geert Carmeliet
Genomic actions induced by 1α25-dihydroxyvitamin D3 [1,25(OH)2D3] are crucial for normal bone metabolism, mainly because they regulate active intestinal calcium transport. To evaluate whether the vitamin D receptor (VDR) has a specific role in growth-plate development and endochondral bone formation, we investigated mice with conditional inactivation of VDR in chondrocytes. Growth-plate chondrocyte development was not affected by the lack of VDR. Yet vascular invasion was impaired, and osteoclast number was reduced in juvenile mice, resulting in increased trabecular bone mass. In vitro experiments confirmed that VDR signaling in chondrocytes directly regulated osteoclastogenesis by inducing receptor activator of NF-κB ligand (RANKL) expression. Remarkably, mineral homeostasis was also affected in chondrocyte-specific VDR-null mice, as serum phosphate and 1,25(OH)2D levels were increased in young mice, in whom growth-plate activity is important. Both in vivo and in vitro analysis indicated that VDR inactivation in chondrocytes reduced the expression of FGF23 by osteoblasts and consequently led to increased renal expression of 1α-hydroxylase and of sodium phosphate cotransporter type IIa. Taken together, our findings provide evidence that VDR signaling in chondrocytes is required for timely osteoclast formation during bone development and for the endocrine action of bone in phosphate homeostasis.

27 March 2012 in Nature Reviews Rheumatology
Verified
Journal Article
Closed access
CMChrista Maes
Christa Maes
GCGeert Carmeliet
Geert Carmeliet
ESErnestina Schipani
Ernestina Schipani

21 January 2003 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
ISIngeborg Stalmans
Ingeborg Stalmans
DLDiether Lambrechts
Diether Lambrechts
Frederik De SmetFrederik De Smet
Frederik De Smet
SJSandra Jansen
Sandra Jansen
JWJian Wang
Jian Wang
PCPeter Carmeliet
Peter Carmeliet